|
3575
|
AMG510
|
Highly potent, selective, and orally bioavailable KRAS-G12C inhibitor |
€90.00
|
|
3084
|
ARS-1620
|
Potent, selective, and orally bioavailable covalent KRAS-G12C inhibitor |
€145.00
|
|
3053
|
BAY-293
|
Potent, selective and cell-active inhibitor of KRAS-SOS1 interaction |
€140.00
|
|
3471
|
BI-3406
|
Inhibitor of KRAS/Son of Sevenless 1 (SOS1) interaction |
Inquire
|
|
2397
|
BQU 57
|
Inhibitor of the RAS-like small GTPases RalA and RalB |
€125.00
|
|
2184
|
CID 1067700
|
First inhibitor of Rab7 GTPase |
€125.00
|
|
2351
|
EHop 016
|
Rac GTPase inhibitor specific for Rac1 and Rac3 |
€85.00
|
|
2829
|
Fendiline hydrochloride
|
KRAS inhibitor; Ca2+ channel blocker (L-type voltage gated) |
€50.00
|
|
3768
|
GDC-6036
|
Inhibitor of KRAS G12C |
Inquire
|
|
2302
|
Kobe 0065
|
HRAS inhibitor |
€70.00
|
|
2017
|
ML 210
|
Chemical probe that selectively kills cells induced to express mutant RAS |
€115.00
|
|
3761
|
MRTX1133
|
First-in-class, noncovalent, selective & reversible inhibitor of KRASG12D mutant |
€220.00
|
|
3733
|
MRTX1257
|
Irreversible covalent inhibitor of KRAS G12C |
Inquire
|
|
1578
|
NSC 23766
|
Rac1 inhibitor |
€110.00
|
|
2396
|
RBC 8
|
Inhibitor of the RAS-like small GTPases RalA and RalB |
€105.00
|
|
2138
|
ZCL 278
|
Cdc42 GTPase inhibitor, targeting Cdc42–ITSN interaction |
€105.00
|
|
3790
|
ZINC69391
|
Specific Rac1 inhibitor |
€110.00
|